{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:16:19Z","timestamp":1793153779915,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG020506"],"award-info":[{"award-number":["T32AG020506"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5R35NS122257"],"award-info":[{"award-number":["5R35NS122257"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmb.2023.168023","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T22:36:28Z","timestamp":1677105388000},"page":"168023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Mechanisms of Glucocerebrosidase Dysfunction in Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"435","author":[{"given":"Diptaman","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2023.168023_b0005","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmb.2023.168023_b0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ana.20102","article-title":"Time to move beyond nigrostriatal dopamine deficiency in Parkinson\u2019s disease","volume":"55","author":"Lang","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0015","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, Present, and Future of Parkinson\u2019s Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0025","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0040","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"International Parkinson\u2019s Disease Genomics Consortium (IPDGC), Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0045","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson\u2019s Disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher Disease Glucocerebrosidase and \u03b1-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168023_b0055","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A Gene Network Regulating Lysosomal Biogenesis and Function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168023_b0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0006-291X(91)90127-S","article-title":"Isolation and sequencing of a cDNA clone encoding 85kDa sialoglycoprotein in rat liver lysosomal membranes","volume":"178","author":"Fujita","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0070","doi-asserted-by":"crossref","unstructured":"M.A. Woeste, D. Wachten, The Enigmatic Role of GBA2 in Controlling Locomotor Function, Front. Mol. Neurosci. 10 (2017). https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2017.00386 (accessed December 12, 2022).","DOI":"10.3389\/fnmol.2017.00386"},{"key":"10.1016\/j.jmb.2023.168023_b0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmb.2023.168023_b0080","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.3390\/ijms23105842","article-title":"Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism","volume":"23","author":"Furderer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmb.2023.168023_b0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jmb.2023.168023_b0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jmb.2023.168023_b0095","article-title":"Classification of GBA1 variants in Parkinson\u2019s disease; the GBA1-PD browser","author":"Parlar","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type 1 Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM: Int. J. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B","article-title":"Parkinson\u2019s syndrome preceding clinical manifestation of Gaucher\u2019s disease","volume":"61","author":"Machaczka","year":"1999","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jmb.2023.168023_b0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jmb.2023.168023_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00702-021-02421-0","article-title":"Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson\u2019s disease: mutational spectrum and clinical features","volume":"129","author":"Lim","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jmb.2023.168023_b0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Migdalska-Richards","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jmb.2023.168023_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135816","article-title":"Identification of GBA mutations among neurodegenerative disease patients from eastern India","volume":"751","author":"Biswas","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jmb.2023.168023_b0135","doi-asserted-by":"crossref","unstructured":"D.A. Olszewska, A. McCarthy, A.I. Soto-Beasley, R.L. Walton, B. Magennis, R.L. McLaughlin, O. Hardiman, O.A. Ross, T. Lynch, Association Between Glucocerebrosidase Mutations and Parkinson\u2019s Disease in Ireland, Front. Neurol. 11 (2020). https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.00527 (accessed November 8, 2022).","DOI":"10.3389\/fneur.2020.00527"},{"key":"10.1016\/j.jmb.2023.168023_b0140","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/mds.28112","article-title":"A Large-Scale Full GBA1 Gene Screening in Parkinson\u2019s Disease in the Netherlands","volume":"35","author":"den Heijer","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0145","first-page":"748335","article-title":"Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson\u2019s disease cohort","author":"Graham","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0150","doi-asserted-by":"crossref","unstructured":"E.K. Gustavsson, S. Sethi, Y. Gao, J. Brenton, S. Garc\u00eda-Ruiz, D. Zhang, R. Garza, R.H. Reynolds, et al., Pseudogenes limit the identification of novel common transcripts generated by their parent genes, (2022) 2022.10.21.513169. https:\/\/doi.org\/10.1101\/2022.10.21.513169.","DOI":"10.1101\/2022.10.21.513169"},{"key":"10.1016\/j.jmb.2023.168023_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03610-7","article-title":"Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson\u2019s disease-associated GBA gene","volume":"5","author":"Toffoli","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jmb.2023.168023_b0160","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ana.24781","article-title":"for the I.G. of P.D.P. (IGPP) Consortium, Specifically neuropathic Gaucher\u2019s mutations accelerate cognitive decline in Parkinson\u2019s","volume":"80","author":"Liu","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0165","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.102959","article-title":"Generation of Parkinson\u2019s disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene","volume":"65","author":"Lee","year":"2022","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.jmb.2023.168023_b0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.parkreldis.2014.09.003","article-title":"Glucocerebrosidase mutations in primary parkinsonism","volume":"20","author":"Asselta","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamaneurol.2016.2245","article-title":"Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease","volume":"73","author":"Davis","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0185","article-title":"T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis, Neurology","volume":"2","author":"Mallett","year":"2016","journal-title":"Genetics"},{"key":"10.1016\/j.jmb.2023.168023_b0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson\u2019s disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0195","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp-2012-302402","article-title":"A clinical and family history study of Parkinson\u2019s disease in heterozygous glucocerebrosidase mutation carriers","volume":"83","author":"McNeill","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jmb.2023.168023_b0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"Anheim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0205","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0210","doi-asserted-by":"crossref","unstructured":"G.J. Lopez, J. Lichtenberg, N. Tayebi, E. Ryan, A.L. Lecker, E. Sidransky, Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson\u2019s disease, Front. Neurol. 13 (2022). https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1039214 (accessed November 8, 2022).","DOI":"10.3389\/fneur.2022.1039214"},{"key":"10.1016\/j.jmb.2023.168023_b0215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.parkreldis.2019.04.016","article-title":"Glucocerebrosidase mutations and phenoconversion of REM sleep behavior disorder to parkinsonism and dementia","volume":"65","author":"Honeycutt","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0220","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp-2017-317348","article-title":"Features of GBA-associated Parkinson\u2019s disease at presentation in the UK Tracking Parkinson\u2019s study","volume":"89","author":"Malek","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jmb.2023.168023_b0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort","volume":"136","author":"Winder-Rhodes","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0230","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2020-322857","article-title":"Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson\u2019s disease","volume":"91","author":"Stoker","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jmb.2023.168023_b0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13041-020-00637-x","article-title":"Characterization of a pathogenic variant in GBA for Parkinson\u2019s disease with mild cognitive impairment patients","volume":"13","author":"Jiang","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.24945","article-title":"Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers","volume":"27","author":"McNeill","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0250","article-title":"Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease","author":"Oftedal","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.12.014","article-title":"A \u201cdose\u201d effect of mutations in the GBA gene on Parkinson\u2019s disease phenotype","volume":"36","author":"Thaler","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0260","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","article-title":"Comparison of Parkinson risk in Ashkenazi Jewish Gaucher patients and GBA heterozygotes","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0265","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0270","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","article-title":"GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology","volume":"79","author":"Tsuang","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0275","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/mds.28225","article-title":"GBA Variants in Parkinson\u2019s Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes","volume":"35","author":"Greuel","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0280","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.26302","article-title":"Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers","volume":"91","author":"Pal","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0285","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/s41467-022-34732-5","article-title":"Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects","volume":"13","author":"Krohn","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes \u2014 key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/acn3.185","article-title":"Variants associated with Gaucher disease in multiple system atrophy","volume":"2","author":"Mitsui","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0300","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/ene.12086","article-title":"No association of GBA mutations and multiple system atrophy","volume":"20","author":"Srulijes","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0305","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","article-title":"Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s Progression Markers Initiative (PPMI): a cross-sectional study","volume":"19","author":"Simuni","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0315","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.29047","article-title":"Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review","volume":"37","author":"Filippi","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2010.10.007","article-title":"A monozygotic twin pair with highly discordant Gaucher phenotypes","volume":"46","author":"Biegstraaten","year":"2011","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.27916","article-title":"Clinical Evaluation of Sibling Pairs With Gaucher Disease Discordant for Parkinsonism","volume":"35","author":"Lopez","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0330","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41467-021-21027-4","article-title":"The docking of synaptic vesicles on the presynaptic membrane induced by \u03b1-synuclein is modulated by lipid composition","volume":"12","author":"Man","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0335","doi-asserted-by":"crossref","unstructured":"J. Burr\u00e9, The Synaptic Function of \u03b1-Synuclein, J. Parkinsons Dis. 5 (n.d.) 699\u2013713. https:\/\/doi.org\/10.3233\/JPD-150642.","DOI":"10.3233\/JPD-150642"},{"key":"10.1016\/j.jmb.2023.168023_b0340","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-Synuclein Gene Identified in Families with Parkinson\u2019s Disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168023_b0345","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168023_b0350","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0355","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1-synuclein causes parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0360","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2023.168023_b0375","doi-asserted-by":"crossref","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein Locus Triplication Causes Parkinson\u2019s Disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168023_b0380","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2023.168023_b0385","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nbd.2018.09.015","article-title":"Path mediation analysis reveals GBA impacts Lewy body disease status by increasing \u03b1-synuclein levels","volume":"121","author":"G\u00fcndner","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0390","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","article-title":"Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson\u2019s Disease and Dementia with Lewy Bodies","volume":"56","author":"Moors","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jmb.2023.168023_b0395","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/brain\/awz350","article-title":"Genetic modifiers of risk and age at onset in GBA associated Parkinson\u2019s disease and Lewy body dementia","volume":"143","author":"Blauwendraat","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0400","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168023_b0405","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1073\/pnas.1717590115","article-title":"LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson\u2019s disease","volume":"115","author":"Nguyen","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2023.168023_b0410","doi-asserted-by":"crossref","first-page":"eaau6870","DOI":"10.1126\/scitranslmed.aau6870","article-title":"A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson\u2019s disease","volume":"11","author":"Burbulla","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0415","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"\u03b1-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168023_b0420","doi-asserted-by":"crossref","first-page":"eabm6393","DOI":"10.1126\/sciadv.abm6393","article-title":"Mutant glucocerebrosidase impairs \u03b1-synuclein degradation by blockade of chaperone-mediated autophagy","volume":"8","author":"Kuo","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jmb.2023.168023_b0425","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/brain\/awab371","article-title":"Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote \u03b1-synuclein aggregation","volume":"145","author":"Galvagnion","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0430","article-title":"Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein mediated neurodegeneration","author":"Yu","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105513","article-title":"Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological \u03b1-synuclein spread in the prodromal preformed fibrils model in young mice","volume":"159","author":"Johnson","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0440","doi-asserted-by":"crossref","first-page":"e0238075","DOI":"10.1371\/journal.pone.0238075","article-title":"L444P Gba1 mutation increases formation and spread of \u03b1-synuclein deposits in mice injected with mouse \u03b1-synuclein pre-formed fibrils","volume":"15","author":"Migdalska-Richards","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168023_b0445","article-title":"Neuronopathic GBA1L444P mutation accelerates Glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions","author":"Mahoney-Crane","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0450","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","article-title":"Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis","volume":"22","author":"Henderson","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","article-title":"Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term","volume":"135","author":"Rey","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168023_b0460","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JPD-191590","article-title":"Loss of One Engrailed1 Allele Enhances Induced \u03b1-Synucleinopathy","volume":"9","author":"Chatterjee","year":"2019","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0465","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","article-title":"Glucocerebrosidase activity modulates neuronal susceptibility to pathological \u03b1-synuclein insult","volume":"105","author":"Henderson","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2023.168023_b0470","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0475","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0480","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","article-title":"Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease","volume":"14","author":"Huebecker","year":"2019","journal-title":"Mol. Neurodegenerat."},{"key":"10.1016\/j.jmb.2023.168023_b0485","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.26278","article-title":"No evidence for substrate accumulation in Parkinson brains with GBA mutations","volume":"30","author":"Gegg","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0490","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease","volume":"88","author":"Boutin","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmb.2023.168023_b0495","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","article-title":"Glucosylsphingosine Promotes \u03b1-Synuclein Pathology in Mutant GBA-Associated Parkinson\u2019s Disease","volume":"37","author":"Taguchi","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0500","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mds.28846","article-title":"Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson\u2019s Disease","volume":"37","author":"Surface","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0505","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/mds.28472","article-title":"The Mutation Matters: CSF Profiles of GCase, Sphingolipids, \u03b1-Synuclein in PDGBA","volume":"36","author":"Lerche","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0510","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.conb.2021.11.004","article-title":"GBA mutations, glucosylceramide and Parkinson\u2019s disease","volume":"72","author":"Milenkovic","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jmb.2023.168023_b0515","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168023_b0520","doi-asserted-by":"crossref","unstructured":"M.J. Peterschmitt, H. Saiki, T. Hatano, T. Gasser, S.H. Isaacson, S.J.M. Gaemers, P. Minini, S. Saubadu, et al., Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson\u2019s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial, J. Parkinsons Dis. 12 (n.d.) 557\u2013570. https:\/\/doi.org\/10.3233\/JPD-212714.","DOI":"10.3233\/JPD-212714"},{"key":"10.1016\/j.jmb.2023.168023_b0525","doi-asserted-by":"crossref","unstructured":"N. Plotegher, L. Bubacco, E. Greggio, L. Civiero, Ceramides in Parkinson\u2019s Disease: From Recent Evidence to New Hypotheses, Front. Neurosci. 13 (2019). https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2019.00330 (accessed December 12, 2022).","DOI":"10.3389\/fnins.2019.00330"},{"key":"10.1016\/j.jmb.2023.168023_b0530","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/hmg\/ddac047","article-title":"Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity","volume":"31","author":"Kim","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0535","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00401-021-02367-3","article-title":"Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders","volume":"142","author":"Kurzawa-Akanbi","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168023_b0540","first-page":"27","article-title":"Parkinson\u2019s disease prevalence in Fabry disease: A survey study","volume":"14","author":"Wise","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.jmb.2023.168023_b0545","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.29163","article-title":"Glycosphingolipid Changes in Plasma in Parkinson\u2019s Disease Independent of Glucosylceramide Levels","volume":"37","author":"te Vruchte","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0550","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1038\/emm.2014.128","article-title":"Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and \u03b1-synuclein aggregation","volume":"47","author":"Bae","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0555","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Sch\u00f6ndorf","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0560","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1093\/hmg\/ddv297","article-title":"Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells","volume":"24","author":"Awad","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0565","doi-asserted-by":"crossref","first-page":"e1007694","DOI":"10.1371\/journal.pgen.1007694","article-title":"Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles","volume":"14","author":"Thomas","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0570","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/hmg\/ddz229","article-title":"Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity","volume":"29","author":"Valdez","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0575","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0872-6","article-title":"Impaired \u03b2-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations","volume":"7","author":"Arrant","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0580","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association Between Progranulin and Gaucher Disease","volume":"11","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jmb.2023.168023_b0585","doi-asserted-by":"crossref","first-page":"e0212382","DOI":"10.1371\/journal.pone.0212382","article-title":"Progranulin deficiency leads to reduced glucocerebrosidase activity","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168023_b0590","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.cell.2021.08.002","article-title":"Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic","volume":"184","author":"Logan","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168023_b0595","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","article-title":"LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients","volume":"10","author":"Ysselstein","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0600","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mds.27994","article-title":"Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition","volume":"35","author":"Sanyal","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0605","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbrc.2016.08.082","article-title":"LRRK2 deficiency impacts ceramide metabolism in brain","volume":"478","author":"Ferrazza","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0610","doi-asserted-by":"crossref","first-page":"e215845","DOI":"10.1001\/jamanetworkopen.2021.5845","article-title":"Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression","volume":"4","author":"Ortega","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jmb.2023.168023_b0615","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.12.014","article-title":"Carriers of both GBA and LRRK2 mutations, compared to carriers of either, Parkinson\u2019s disease: Risk estimates and genotype-phenotype correlations","volume":"62","author":"Yahalom","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0620","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","volume":"46","author":"Bendikov-Bar","year":"2011","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0625","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13041-020-00712-3","article-title":"Fibroblasts from idiopathic Parkinson\u2019s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2","volume":"14","author":"Thomas","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0630","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","article-title":"ER Stress and Autophagic Perturbations Lead to Elevated Extracellular \u03b1-Synuclein in GBA-N370S Parkinson\u2019s iPSC-Derived Dopamine Neurons","volume":"6","author":"Fernandes","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jmb.2023.168023_b0635","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddac233","article-title":"The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines","author":"Smith","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0640","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0645","doi-asserted-by":"crossref","first-page":"e21967","DOI":"10.1002\/syn.21967","article-title":"Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate","volume":"71","author":"Migdalska-Richards","year":"2017","journal-title":"Synapse"},{"key":"10.1016\/j.jmb.2023.168023_b0650","first-page":"427","article-title":"Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial, JAMA","volume":"77","author":"Mullin","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2023.168023_b0655","doi-asserted-by":"crossref","unstructured":"T.-U. Han, R. Sam, E. Sidransky, Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease, Front. Cell Dev. Biol. 8 (2020). https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2020.00271 (accessed February 9, 2023).","DOI":"10.3389\/fcell.2020.00271"},{"key":"10.1016\/j.jmb.2023.168023_b0660","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuron.2021.10.032","article-title":"Rescue of \u03b1-synuclein aggregation in Parkinson\u2019s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking","volume":"110","author":"Stojkovska","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2023.168023_b0665","doi-asserted-by":"crossref","first-page":"e79830","DOI":"10.7554\/eLife.79830","article-title":"Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy","volume":"11","author":"Boddupalli","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168023_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and Astrocyte Dysfunction in Parkinson\u2019s Disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0675","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-022-02574-z","article-title":"Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jmb.2023.168023_b0680","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1474-4422(17)30244-2","article-title":"Imaging neuroinflammation to monitor \u03b1-synucleinopathy","volume":"16","author":"Ouchi","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jmb.2023.168023_b0685","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/brain\/awz104","article-title":"Temporal evolution of microglia and \u03b1-synuclein accumulation following foetal grafting in Parkinson\u2019s disease","volume":"142","author":"Olanow","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2023.168023_b0690","doi-asserted-by":"crossref","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-022-00724-0","article-title":"Inflammation promotes synucleinopathy propagation","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0700","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"\u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0705","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells of Parkinson\u2019s disease patients recognize \u03b1\u2013synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168023_b0710","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12974-021-02272-2","article-title":"Inhibition of microglial \u03b2-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons","volume":"18","author":"Brunialti","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jmb.2023.168023_b0715","doi-asserted-by":"crossref","unstructured":"Z. Zhang, X. Wang, Y. Lin, D. Pan, A multifaceted evaluation of microgliosis and differential cellular dysregulation of mammalian target of rapamycin signaling in neuronopathic Gaucher disease, Front. Mol. Neurosci. 15 (2022). https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.944883 (accessed December 12, 2022).","DOI":"10.3389\/fnmol.2022.944883"},{"key":"10.1016\/j.jmb.2023.168023_b0720","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/ars.2015.6307","article-title":"Sustained Systemic Glucocerebrosidase Inhibition Induces Brain \u03b1-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice","volume":"23","author":"Rocha","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jmb.2023.168023_b0725","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2023.168023_b0730","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/ddt468","article-title":"Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration","volume":"23","author":"Farfel-Becker","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0735","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","article-title":"Neuroinflammation and \u03b1-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction","volume":"111","author":"Ginns","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jmb.2023.168023_b0740","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nbd.2018.12.001","article-title":"Development and biochemical characterization of a mouse model of Parkinson\u2019s disease bearing defective glucocerebrosidase activity","volume":"124","author":"Mus","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jmb.2023.168023_b0745","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/hmg\/ddx120","article-title":"Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration","volume":"26","author":"Soria","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168023_b0750","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2023.168023_b0755","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/mds.28496","article-title":"Profiling the Biochemical Signature of GBA-Related Parkinson\u2019s Disease in Peripheral Blood Mononuclear Cells","volume":"36","author":"Avenali","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0760","doi-asserted-by":"crossref","first-page":"E3285","DOI":"10.1073\/pnas.1618133114","article-title":"Intracellular metabolite \u03b2-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity","volume":"114","author":"Nagata","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2023.168023_b0765","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.892899","article-title":"WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson\u2019s Disease Monocytes","volume":"16","author":"Wallings","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0770","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3233\/JPD-212624","article-title":"Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers","volume":"11","author":"Thaler","year":"2021","journal-title":"JPD."},{"key":"10.1016\/j.jmb.2023.168023_b0775","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/mds.28525","article-title":"Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease","volume":"36","author":"Galper","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0780","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10517-020-04723-x","article-title":"Plasma Cytokines Profile in Patients with Parkinson\u2019s Disease Associated with Mutations in GBA Gene","volume":"168","author":"Miliukhina","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.jmb.2023.168023_b0785","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","article-title":"Stem-cell-derived human microglia transplanted in mouse brain to study human disease","volume":"22","author":"Mancuso","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jmb.2023.168023_b0790","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41596-020-00447-4","article-title":"Stem-cell-derived human microglia transplanted into mouse brain to study human disease","volume":"16","author":"Fattorelli","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jmb.2023.168023_b0795","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable Mouse Models of Acid \u03b2-Glucosidase Deficiency: The Defect in Gaucher Disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jmb.2023.168023_b0800","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/dna.1991.10.15","article-title":"Heterogeneity of Mutations in the Acid \u03b2-Glucosidase Gene of Gaucher Disease Patients","volume":"10","author":"Latham","year":"1991","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jmb.2023.168023_b0805","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40478-018-0538-9","article-title":"D409H GBA1 mutation accelerates the progression of pathology in A53T \u03b1-synuclein transgenic mouse model","volume":"6","author":"Kim","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jmb.2023.168023_b0810","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/mds.28144","article-title":"Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson\u2019s Disease Onset","volume":"35","author":"Schierding","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0815","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/mds.28987","article-title":"Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson\u2019s Disease Risk","volume":"37","author":"Straniero","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0820","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.stemcr.2022.08.010","article-title":"Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson\u2019s disease","volume":"17","author":"Drouin-Ouellet","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jmb.2023.168023_b0825","first-page":"52","article-title":"Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors","volume":"7","author":"Qin","year":"2020","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.jmb.2023.168023_b0830","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/mds.28815","article-title":"Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity","volume":"36","author":"Ysselstein","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jmb.2023.168023_b0835","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200553119","article-title":"A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells","volume":"119","author":"Deen","year":"2022","journal-title":"J Proc. Natl. Acad. Sci."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:27:01Z","timestamp":1762669621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283623000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":167,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0022283623000797"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168023","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of Glucocerebrosidase Dysfunction in Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"168023"}}